Inventor · disambiguated record
Valeria Ossovskaya
Also filed as: OSSOVSKAYA VALERIA · OSSOVSKAYA VALERIA S
9 granted patents·20 pending applications·114 citations·filing 2000–2017
88Inventor score
Files withBIPAR SCIENCES INC14RIGEL PHARMACEUTICALS INC3BIPAR SCIENCES2MOORE JEROME2OSSOVSKAYA VALERIA2
Top patents by PatentIndex Score
29 records- 0193US7732491B2Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agentsBIPAR SCIENCES INC·Filed 2008·Granted Jun 8, 2010·35 cites·10 claims
- 0292US7405227B2Treatment of cancerBIPAR SCIENCES INC·Filed 2006·Granted Jul 29, 2008·35 cites·8 claims
- 0389US7538252B2Drug design for tubulin inhibitors, compositions, and methods of treatment thereofBIPAR SCIENCES INC·Filed 2007·Granted May 26, 2009·20 cites·5 claims
- 0482US8377985B2Treatment of cancerBIPAR SCIENCES INC·Filed 2008·Granted Feb 19, 2013·5 cites·9 claims
- 0582US7994222B2Monitoring of the inhibition of fatty acid synthesis by iodo-nitrobenzamide compoundsBIPAR SCIENCES INC·Filed 2007·Granted Aug 9, 2011·7 cites·12 claims
- 0681US8143447B2Treatment of cancerMOORE JEROME·Filed 2007·Granted Mar 27, 2012·4 cites·4 claims
- 0779US6887675B1Tankyrase H, compositions involved in the cell cycle and methods of useRIGEL PHARMACEUTICALS INC·Filed 2001·Granted May 3, 2005·7 cites·10 claims
- 0867US2009123419A1Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agentsBIPAR SCIENCES·Filed 2008·Application pending·0 cites
- 0967US2010009930A1Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in conbination with anti-tumor agentsBIPAR SCIENCES INC·Filed 2009·Application pending·0 cites
- 1062US2010003192A1Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agentsBIPAR SCIENCES INC·Filed 2009·Application pending·0 cites
- 1159US2009149397A1Treatment of cancer with combinations of topoisomerase inhibitors and parp inhibitorsBIPAR SCIENCES·Filed 2008·Application pending·0 cites
- 1257US2009291924A1Drug design for tubulin inhibitors, compositions, and methods of treatment thereofBIPAR SCIENCES INC·Filed 2009·Application pending·0 cites
- 1355US7723018B2Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascadeRIGEL PHARMACEUTICALS INC·Filed 2003·Granted May 25, 2010·1 cites·13 claims
- 1453US2010160442A1Formulations for cancer treatmentOSSOVSKAYA VALERIA S·Filed 2009·Application pending·0 cites
- 1552US6617102B1Tankyrase H, compositions involved in the cell cycle and methods of useRIGEL PHARMACEUTICALS INC·Filed 2000·Granted Sep 9, 2003·0 cites·4 claims
- 1652US2012238601A1Treatment of cancerMOORE JEROME·Filed 2011·Application pending·0 cites
- 1752US2013331457A1Treatment of cancerBIPAR SCIENCES INC·Filed 2012·Application pending·0 cites
- 1850US2012269861A1Treatment of breast cancer with iodonitrobenzamides in combination with anti-tumor agentsSHERMAN BARRY M·Filed 2012·Application pending·0 cites
- 1948US2009149417A1Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitorsOSSOVSKAYA VALERIA·Filed 2008·Application pending·0 cites
- 2048US2009275608A1Methods of diagnosing and treating parp-mediated diseasesBIPAR SCIENCES INC·Filed 2009·Application pending·0 cites
- 2148US2005074825A1Tankyrase H, compositions involved in the cell cycle and methods of useFiled 2003·Application pending·0 cites
- 2246US2008176946A1Formulations for cancer treatmentBIPAR SCIENCES INC·Filed 2008·Application pending·0 cites
- 2345US2008262062A1Method of treating diseases with parp inhibitorsBIPAR SCIENCES INC·Filed 2007·Application pending·0 cites
- 2444US2008076778A1Methods for designing parp inhibitors and uses thereofBIPAR SCIENCES INC·Filed 2007·Application pending·0 cites
- 2544US2007292883A1Method of treating diseases with PARP inhibitorsOSSOVSKAYA VALERIA S·Filed 2007·Application pending·0 cites
- 2643US2012004260A1Inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds and methods of treatment thereofOSSOVSKAYA VALERIA·Filed 2011·Application pending·0 cites
- 2740US2012130144A1Treatment of lung cancer with a nitrobenzamide compound in combination with a growth factor inhibitorSHERMAN BARRY M·Filed 2010·Application pending·0 cites
- 2836US2019154692A1Compositions and methods for screening, monitoring and treating gastrointestinal diseasesBIOCRYPTON INC·Filed 2017·Application pending·0 cites
- 2933US2010279327A1Method of treating diseases with parp inhibitorsBIPAR SCIENCES INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →